Aktie TZACU TENZING ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Tenzing Acquisition Corp. Nasdaq

Aktien

TZACU

VGG8708A1241

TZACU

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim Group Inaugural 2021 Emerging Growth Virtual Conference
REVIVA PHARMACEUTICALS : Changes in Registrant's Certifying Accountant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K/A)
REVIVA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
REVIVA PHARMACEUTICALS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Amendment or Waiver to Code of Ethics, (form 8-K)
Tenzing Acquisition Corp.(NasdaqCM:TZAC) dropped from NASDAQ Composite Index
Reviva Pharmaceuticals, Inc. completed the acquisition of Tenzing Acquisition Corp. in a reverse merger transaction.
Tenzing Acquisition Corp. announced that it has received $0.2 million in funding from Tenzing LLC
Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce the Appointment of Narayan Prabhu as Chief Financial Officer
Tenzing Acquisition Corp. Reports Earnings Results for the Second Quarter Ended August 31, 2020
Tenzing Acquisition Corp. announced that it has received $0.35 million in funding from Tenzing LLC
Tenzing Acquisition Corp. announced that it has received $0.125 million in funding from Tenzing LLC
Tenzing Acquisition Corp. announced that it has received $0.175 million in funding from Tenzing LLC
Tenzing Acquisition Corp. : and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination
Reviva Pharmaceuticals, Inc. entered into a definitive agreement to acquire Tenzing Acquisition Corp. for $64 million in a reverse merger transaction.
Tenzing Acquisition Corp. Reports Earnings Results for the First Quarter Ended May 31, 2020
Tenzing Acquisition Corp. : Announces Extension of Deadline to Complete a Business Combination
Tenzing Acquisition Corp. Reports Earnings Results for the Full Year Ended February 29, 2020
Tenzing Acquisition Corp. : Announces Extension of Deadline to Complete a Business Combination
Tenzing Acquisition Corp. announced that it has received $0.75 million in funding from Tenzing LLC
Tenzing Acquisition Corp. Reports Earnings Results for the Third Quarter Ended November 30, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QK7Q Aktie
  4. TZACU Aktie
  5. Nachrichten Tenzing Acquisition Corp.
  6. Andere Sprachen